Ensign Peak Advisors’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-456,841
| Closed | -$4.23M | – | 1731 |
|
|
2023
Q4 | $4.23M | Buy |
456,841
+85,285
| +23% | +$790K | 0.01% | 668 |
|
|
2023
Q3 | $3.76M | Sell |
371,556
-324,035
| -47% | -$3.28M | 0.01% | 651 |
|
|
2023
Q2 | $8.69M | Buy |
695,591
+26,987
| +4% | +$337K | 0.02% | 454 |
|
|
2023
Q1 | $7.8M | Buy |
668,604
+24,560
| +4% | +$287K | 0.02% | 459 |
|
|
2022
Q4 | $6.85M | Sell |
644,044
-143,107
| -18% | -$1.52M | 0.02% | 485 |
|
|
2022
Q3 | $7.64M | Buy |
787,151
+431,939
| +122% | +$4.19M | 0.02% | 425 |
|
|
2022
Q2 | $5.15M | Buy |
355,212
+145,204
| +69% | +$2.1M | 0.01% | 527 |
|
|
2022
Q1 | $5.49M | Sell |
210,008
-280,148
| -57% | -$7.32M | 0.01% | 564 |
|
|
2021
Q4 | $19.4M | Buy |
490,156
+739
| +0.2% | +$29.3K | 0.04% | 325 |
|
|
2021
Q3 | $24.5M | Buy |
489,417
+166,143
| +51% | +$8.31M | 0.05% | 283 |
|
|
2021
Q2 | $17.9M | Sell |
323,274
-3,841
| -1% | -$213K | 0.04% | 331 |
|
|
2021
Q1 | $15.3M | Sell |
327,115
-6,230
| -2% | -$291K | 0.03% | 351 |
|
|
2020
Q4 | $14.5M | Buy |
333,345
+34,280
| +11% | +$1.49M | 0.03% | 364 |
|
|
2020
Q3 | $10.9M | Buy |
299,065
+12,324
| +4% | +$451K | 0.03% | 425 |
|
|
2020
Q2 | $8.36M | Buy |
286,741
+36,582
| +15% | +$1.07M | 0.02% | 465 |
|
|
2020
Q1 | $6.54M | Buy |
250,159
+38,812
| +18% | +$1.01M | 0.02% | 449 |
|
|
2019
Q4 | $7.33M | Buy |
+211,347
| New | +$7.33M | 0.02% | 537 |
|